A group of researchers in Israel has concluded that an mRNA-based vaccine could activate herpes zoster (shingles) in a limited number of people with rheumatic diseases. The viral infection, which can cause a painful rash, is caused by the varicella-zoster virus, which is also responsible for chickenpox. In a study focusing on individuals with autoimmune…